WebApr 13, 2024 · Therapeutic areas Products R&D Commitments Ipsen Map About Us Ipsen is a global specialty-driven pharmaceutical company and also has a significant presence in consumer healthcare. Our ambition is to become a leader in the treatment of targeted debilitating diseases. Ipsen Group Ipsen Nordics Locations Oncology Prostate cancer … WebInspiring hope, improving patients' lives. We are a global biopharmaceutical leader dedicated to improving lives through innovative medicines in oncology, neuroscience, and rare …
Welcome to Ipsen Global Medical Information (GMI)
WebPrimary biliary cholangitis (PBC) is a chronic disease in which bile ducts in the liver are gradually destroyed[1]. This results in bile accumulating in the liver, contributing to tissue damage and scarring, or fibrosis, that results in cirrhosis. WebApr 13, 2024 · Endocrinology is the therapeutic area that deals with the study of hormones, the chemical substances used by the body for essential functions. Nordics Ipsen in the worldAustraliaBeluxBrazilCanadaChinaCzech republicFranceGermanyGreeceItalyKoreanNetherlandsNordicsPolandRussiaSingaporeSlovakiaSpainUKUSAUkraine … chi town eats columbia mo
Ipsen adds another program into its pre-clinical R&D Oncology …
WebOur research focuses on four key therapeutic areas: Oncology, Cardiometabolism, Immune-Inflammatory and Neuroscience. Our extensive know-how and expertise position us to best address the unmet needs of patients. Servier draws on the excellence of its Research & Development (R&D) employees worldwide to develop effective treatment solutions. Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world’s top 15 biopharmaceutical companies in terms of oncology sales. Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees … WebNov 5, 2024 · Ipsen has automated design and construction of therapeutic candidates using Synthace’s integrative software platform. The process aims to speed up biotherapeutic candidate entry into the screening pipeline and shorten development time for treatment of diseases via targeted secretion inhibition. chitown drive in theater